HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Glowniak, J. V. Articles by Woodward, W. R. Search for Related Content PubMed PubMed Citation Articles by Glowniak, J. V. Articles by Woodward, W. R.

Iodine-123 Metaiodobenzylguanidine Imaging of the Heart in Idiopathic Congestive Cardiomyopathy and Cardiac Transplants

Nuclear Medicine Service and Medical Service, Cardiology Section, Veterans Administration Medical Center
Department of Diagnostic Radiology and Neurology, Oregon Health Sciences University, Portland, Oregon
Crocker Nuclear Laboratory, University of California, Davis, California

Correspondence: For reprints contact: Jerry V. Glowniak, MD, Nuclear Medicine Service, Veterans Administration Medical Center, PO Box 1034, Portland, OR 97207.

ABSTRACT

Iodine-123 metaiodobenzylguanidine ([¹²³I]MIBG) is a norepinephrine analog which can be used to image the sympathetic innervation of the heart. In this study, cardiac imaging with [¹²³I]MIBG was performed in patients with idiopathic congestive cardiomyopathy and compared to normal controls. Initial uptake, half-time of tracer within the heart, and heart to lung ratios were all significantly reduced in patients compared to normals. Uptake in lungs, liver, salivary glands, and spleen was similar in controls and patients with cardiomyopathy indicating that decreased MIBG uptake was not a generalized abnormality in these patients. Iodine-123 MIBG imaging was also performed in cardiac transplant patients to determine cardiac nonneuronal uptake. Uptake in transplants was <10% of normals in the first 2 hr and nearly undetectable after 16 hr. The decreased uptake of MIBG suggests cardiac sympathetic nerve dysfunction while the rapid washout of MIBG from the heart suggests increased cardiac sympathetic nerve activity in idiopathic congestive cardiomyopathy.

This article has been cited by other articles:

				T. Tsukamoto, K. Morita, M. Naya, M. Inubushi, C. Katoh, K. Nishijima, Y. Kuge, H. Okamoto, H. Tsutsui, and N. Tamaki Decreased Myocardial {beta}-Adrenergic Receptor Density in Relation to Increased Sympathetic Tone in Patients with Nonischemic Cardiomyopathy J. Nucl. Med., November 1, 2007; 48(11): 1777 - 1782. [Abstract] [Full Text] [PDF]

				Y. Tanabe, H. Harada, S. Sugihara, T. Ogawa, and Y. Inoue 123I-Metaiodobenzylguanidine Myocardial Scintigraphy in Panic Disorder J. Nucl. Med., August 1, 2004; 45(8): 1305 - 1308. [Abstract] [Full Text] [PDF]

				K. Mardon, O. Montagne, N. Elbaz, Z. Malek, A. Syrota, J.-L. Dubois-Rande, M. Meignan, and P. Merlet Uptake-1 Carrier Downregulates in Parallel with the {beta}-Adrenergic Receptor Desensitization in Rat Hearts Chronically Exposed to High Levels of Circulating Norepinephrine: Implications for Cardiac Neuroimaging in Human Cardiomyopathies J. Nucl. Med., September 1, 2003; 44(9): 1459 - 1466. [Abstract] [Full Text] [PDF]

				S. Kasama, T. Toyama, H. Kumakura, Y. Takayama, S. Ichikawa, T. Suzuki, and M. Kurabayashi Addition of Valsartan to an Angiotensin-Converting Enzyme Inhibitor Improves Cardiac Sympathetic Nerve Activity and Left Ventricular Function in Patients with Congestive Heart Failure J. Nucl. Med., June 1, 2003; 44(6): 884 - 890. [Abstract] [Full Text] [PDF]

				S. Kasama, T. Toyama, H. Kumakura, Y. Takayama, S. Ichikawa, T. Suzuki, and M. Kurabayashi Spironolactone Improves Cardiac Sympathetic Nerve Activity and Symptoms in Patients with Congestive Heart Failure J. Nucl. Med., October 1, 2002; 43(10): 1279 - 1285. [Abstract] [Full Text] [PDF]

				S. Kasama, T. Toyama, H. Hoshizaki, S. Oshima, K. Taniguchi, T. Suzuki, and M. Kurabayashi Dobutamine Gated Blood Pool Scintigraphy Predicts the Improvement of Cardiac Sympathetic Nerve Activity, Cardiac Function, and Symptoms After Treatment in Patients With Dilated Cardiomyopathy* Chest, August 1, 2002; 122(2): 542 - 548. [Abstract] [Full Text] [PDF]

				M. Pissarek, J. Ermert, G. Oesterreich, D. Bier, and H. H. Coenen Relative Uptake, Metabolism, and {beta}-Receptor Binding of (1R,2S)-4-18F-Fluorometaraminol and 123I-MIBG in Normotensive and Spontaneously Hypertensive Rats J. Nucl. Med., March 1, 2002; 43(3): 366 - 373. [Abstract] [Full Text] [PDF]

				A. Druschky, M. J. Hilz, P. Hopp, G. Platsch, M. Radespiel-Troger, K. Druschky, T. Kuwert, H. Stefan, and B. Neundorfer Interictal cardiac autonomic dysfunction in temporal lobe epilepsy demonstrated by [123I]metaiodobenzylguanidine-SPECT Brain, December 1, 2001; 124(12): 2372 - 2382. [Abstract] [Full Text] [PDF]

				T. Wakabayashi, T. Nakata, A. Hashimoto, S. Yuda, K. Tsuchihashi, M. I. Travin, and K. Shimamoto Assessment of Underlying Etiology and Cardiac Sympathetic Innervation to Identify Patients at High Risk of Cardiac Death J. Nucl. Med., December 1, 2001; 42(12): 1757 - 1767. [Abstract] [Full Text] [PDF]

				A. L'Abbate and G. Sambuceti Studying the neuronal side of the synaptic cleft. A tool for investigating the paradox of sympathetic nervous system and heart failure in dilated cardiomyopathy Eur. Heart J., September 1, 2001; 22(17): 1521 - 1522. [PDF]

				E.N Simantirakis, V.K Prassopoulos, S.I Chrysostomakis, G.E Kochiadakis, S.I Koukouraki, J.P Lekakis, N.S Karkavitsas, and P.E Vardas Effects of asynchronous ventricular activation on myocardial adrenergic innervation in patients with permanent dual-chamber pacemakers. An I123-metaiodobenzylguanidine cardiac scintigraphic study Eur. Heart J., February 2, 2001; 22(4): 323 - 332. [Abstract] [PDF]

				U. Lotze, S. Kaepplinger, A. Kober, B. M. Richartz, D. Gottschild, and H. R. Figulla Recovery of the Cardiac Adrenergic Nervous System After Long-Term {beta}-Blocker Therapy in Idiopathic Dilated Cardiomyopathy: Assessment by Increase in Myocardial 123I-Metaiodobenzylguanidine Uptake J. Nucl. Med., January 1, 2001; 42(1): 49 - 54. [Abstract] [Full Text] [PDF]

				F. Sakamaki, T. Satoh, N. Nagaya, S. Kyotani, N. Nakanishi, and Y. Ishida Abnormality of Left Ventricular Sympathetic Nervous Function Assessed by 123I-Metaiodobenzylguanidine Imaging in Patients With COPD* Chest, December 1, 1999; 116(6): 1575 - 1581. [Abstract] [Full Text] [PDF]

				T. Koizumi, K. Kubo, M. Hanaoka, H. Yamamoto, S. Yamaguchi, T. Fujii, and T. Kobayashi Serial Scintigraphic Assessment of Iodine-123 Metaiodobenzylguanidine Lung Uptake in a Patient With High-Altitude Pulmonary Edema Chest, October 1, 1999; 116(4): 1129 - 1131. [Abstract] [Full Text] [PDF]

				A. Cohen-Solal, Y. Esanu, D. Logeart, F. Pessione, C. Dubois, G. Dreyfus, R. Gourgon, and P. Merlet Cardiac metaiodobenzylguanidine uptake in patients with moderate chronic heart failure: relationship with peak oxygen uptake and prognosis J. Am. Coll. Cardiol., March 1, 1999; 33(3): 759 - 766. [Abstract] [Full Text] [PDF]

				F Hartmann, S Ziegler, S Nekolla, M Hadamitzky, M Seyfarth, G Richardt, and M Schwaiger Regional patterns of myocardial sympathetic denervation in dilated cardiomyopathy: an analysis using carbon-11 hydroxyephedrine and positron emission tomography Heart, March 1, 1999; 81(3): 262 - 270. [Abstract] [Full Text]

				C. Kondo, M. Nakazawa, K. Momma, and K. Kusakabe Sympathetic Denervation and Reinnervation After Arterial Switch Operation for Complete Transposition Circulation, June 23, 1998; 97(24): 2414 - 2419. [Abstract] [Full Text] [PDF]